肉瘤中的细胞外囊泡:对瘤进展和治疗的影响
Yue Wang1,2, Shaozhi Gao3, Geng Zhang3
1Central Laboratory, Affiliated Hospital of Putian University, School of Basic Medicine, Putian University, Putian, Fujian Province, 351100, People's Republic of China.
International journal of nanomedicine
|November 20, 2025
概括
细胞外囊泡 (EVs) 是肉瘤进展的关键参与者,推动瘤生长和扩散. 针对这些EV提供了对肉瘤诊断和治疗的新希望.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 肉瘤是一种具有挑战性的癌症,因为它具有攻击性和耐治疗性.
- 细胞外囊泡 (EVs) 在瘤微环境中调解细胞间通信,影响肉瘤的进展.
研究的目的:
- 审查EVs在肉瘤病变发生中的多样性作用.
- 探索基于EV的策略来诊断肉瘤,预后,药物输送和免疫治疗.
主要方法:
- 对最近关于肉瘤中EVs的研究进行了全面的文献综述.
- 在骨髓瘤和脂质瘤中分析亚型特定的EV机制.
- 评估目前和新兴的基于电动汽车的治疗和诊断应用.
主要成果:
- 通过促进上皮质-介质细胞过渡 (EMT),血管生成和免疫逃避,EVs促进了肉瘤的进展.
- 电子瘤显示出作为早期瘤检测和预后的非侵入性生物标志物的潜力.
- 工程电动汽车可以用于向药物输送和在肉瘤中进行免疫治疗.
结论:
- EVs是肉瘤发育和进展的关键调解者.
- 电动瘤代表了开发新型瘤诊断和治疗策略的有希望的途径.
- 进一步研究基于EV的精密医学对于改善肉瘤管理至关重要.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Intralumenal Vesicles and Multivesicular Bodies
4.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.7K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K


